Completed study

Official Study Title
A Double-blind, Randomized, Placebo-controlled Clinical Trial of the Safety and Efficacy of Anakinra in Patients With Hidradenitis Suppurativa

Details
Status: Completed
Study Type: Interventional (Clinical Trial)
Study phase: II
Study sites: 2 sites in Greece
Actual enrolment: 20 participants

ClinicalTrials.gov Identifier: NCT01558375
EudraCT number: 2011-005145-12
National Organization for Medicines Approval: IS 92-11
National Ethics Committee Approval: 100/11

Study Start: March 2012
Study Completion: February 2014

Condition/Disease studied: Hidradenitis Suppurativa

Related publications